MIPS Home MIPS General Information MIPS Grants MIPS Courses MIPS Research MIPS Software MIPS Web Tools MIPS Sitemap
About MIPS MIPS News Faculty & Staff Recent Pubs Directions Facilities Events & Meetings Employment Associated Depts Useful Links
Grant News CCNE-TR CVIS ICMIC ICBP NTROI SMIS
BIOE222 Pharmacokinetics Stats & Data Analysis
BIOE222A F2009 BIOE222B W2009 BIOE222A F2008 BIOE222B W2008 BIOE222A F2007 BIOE222B W2007 BIOE222 F2006 BIOE222 F2005 BIOE222 F2004
Biswal Lab Blankenberg Lab Cheng Lab Contag Lab Felsher Lab Gambhir Lab Graves Lab Guccione Lab Levin Lab Lin Lab McConnell Moseley Lab Paik Lab Plevritis Lab Ramasamy Lab Rao Lab Rutt Lab Schnitzer Lab Vasanawala Lab Willmann Lab Wu Lab Xing Lab
NCIL MRSRL
AMIDE
NucMed Mediabook PET Brain Atlas PET-FDG Whole Body Atlas


Samira Guccione
Samira Guccione
Member, MIPS
Assistant Professor of Radiology
Education:Ph.D., Biomedical Engineering, Johns Hopkins University, 1999
M.S., Chemistry/Math, University of Virginia, Charlottesville, 1995
B.S., Chemistry/Math, University of Virginia, Charlottesville, 1988
Awards:2003 AACR- Bristol-Myers Squibb Oncology Award
2002 ISMRM travel award
2001 AACR-AFLAC Scholar-in-training Award
2000 Certificate of Merit on poster presentation at Radiological Society of North America (RSNA)
2000 – 2002 National Cancer Institute Postdoctoral Fellowship
1995 – 1999 Whitaker Foundation Graduate Fellowship
1984 – 1988 Bachelor of Science Degree in Chemistry with Distinction
1985 – 1986 Deloach Award for outstanding student in organic chemistry
1985 – 1988 Scholarship awarded in chemistry by LaQue Center for Corrosion Technology
Address:Lucas MRS Center, RM P280
1201 Welch Road
Stanford, CA 94305
Phone:650-725-4936
Fax:650-723-5795
E-mail: guccione@stanford.edu
Research Interests:My research interests are primarily on the development of imaging and therapeutic agents targeting the vasculature.
  • We use high throughput genomic and proteomic analysis to evaluate potential targets for imaging and therapy.
  • We have developed a nanoparticle-based molecular imaging probe that targets the integrins (in particular alphavbeta3) on the luminal side of the endothelium.
  • We have used these nanoparticles to image tumor vasculature in models for brain (glioblastoma multiforme), melanoma, and colon metastasis to the liver and lung.
  • We have successfully used a modified form of these nanoparticles for gene delivery to the tumor vasculature. This approach used the dominant negative strategy to disrupt the VEGF and FGF secondary messenger pathway. This anti-angiogenic therapy is being developed for clinical trials.
  • I am also interested in pro-angiogenic (re-vascularization) approaches to develop therapies for ischemic or artificial organs (Tissue engineering). Another area of interest in my lab has been the relationship of stem cells with endothelium in pathologic or inflammed tissue. This is a new area of development in my lab.
There are other smaller side projects in the lab involving drug and gene delivery, radiation sensitizers, and the use of ultrasound for imaging and delivery of therapeutics.
Current Labs:Imaging and Therapeutic Platforms for Translational Medicine
Recent Publications:
  • D'Souza AL, Tseng JR, Butts Pauly K, Guccione S, Rosenberg J, Gambhir SS, Glazer GM. A strategy for blood biomarker amplification and localization using ultrasound. PNAS.2009; 106(40): 17152-17157.



crumpnews events